Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
that show was fun.............he was one proud eccentric...........and IT WORKED!----------My wife thinks me just as fun and silly. Thank god for our 20 years. She let's me think i am DYNOMITE! It's fun.
Should be new posters coming over from IV pays board i started there long ago... soon----------that site is suffering a dreadful hack of porn and such. First one ever, but running into day two already. We have a great board here. Welcome to my friends from IV- anyone new!
WOW, are you suggesting we are sitting on a keg o dyn o mite.
Adding on every dip!
$5.00 calls in play.
HAPPY CAMPER BOARD (-;
On February 21, there was an unprecedented cyberattack on the U.S. health system and the change health care claims and payment infrastructure. This had a substantial impact to consumers, providers and many of our competitors, leaving their pharmaceutical manufacturer clients scrambling for a solution to the prolonged outage.
As a result of the fallout, we were able to secure and launch 8 new programs from 2 manufacturers in less than ten days, adding substantial revenue and approximately 1 million additional claims to our 2024 claims volume. We are confident that this will lead to additional programs in 2024 from these and other manufacturers as we continue to assist our current partners and filled new requests. Much like our payment platform, our patient affordability platform has been purpose-built for high availability and utilizes multiple redundant network connections to assure continuity. These multiple process or connections enabled us to quickly move to other processors not impacted by this event.
"We are pleased that we have been able to provide solutions where the value offered is so compelling that our clients are willing to change mid-program"
Q1 just around the corner. Seems these pharma companies like saving literally MILLIONS with us and giving their patients "white glove" service. Come to Paysign or be left in the stone ages while they rape your pocket and risk the entire system shutting down like this February. Decisions, decisions....
"We've cracked the code"
10 may be conservative....
Volume contracting. Many shortie have covered by now.
Major excitement may have run its course and quiet period
until Q1 #'s.
Evenings watching TV, every 4th or 5th commercial is Pharma.
All conclude with some type of message about "financial assistance".
Somehow $ will end up in PAYS pocketbook from the "financial assistance".
Gives me warm and fuzzy feelings every evening.
New target: $10.
OT- heads up IV posters---looks hacked for the first time there. First time. I've been there for years. Be careful until admin works it out. fwiw
i irresponsibly never keep up or care about shorts this and shorts thjat-----i'm too dense. all i see is our comeback kid coming back with steady volume in a golden mkt until september.---------i will ride our magic carpet------
I think shorts are having margin calls & either have to bring in cash or buy PAYS back.
NEW FIFTY TWO WEEK HIGH....with 5+ coming
WOW, I'm going to lose a few tho @ $5.
Will put more bucks in my acct.
With plenty left for run to $10.
I wish we could get current short interest updates.
Easy double from here imo
PAYS nearing 52 week high--4.43-------------------------------5+ up next
JP, re grfs:
Grifols, S.A. (NASDAQ: GRFS) Short Seller Report: Kaplan Fox Investigates Grifols, S.A.
11:58 AM ET 4/2/24 | Dow Jones
jp, flipped it for $100.
didn't really need odd lots hang'in around.
shortie not happy campers these days
They were having family investor problems over there. Pretty good company though.
took a random look @ GRFS. WTF, fell out of bed, so, grabbed a starter position @ 6.495.
94k shares traded at close. That's about what our daily average used to be. Things heating up......way, way up
every time a wall is put up, it gets SMASHED to ground.
We picked up a new analysist
Michael Diana
Maxim Group
Buy
03/27/24 -- -8.60% 32%
Read Read Article
looking like shortie caught by short hairs
No mention of PATIENT AFFORDABILITY?
Incomplete article! PA will eventually surpass plasma. IMO
I've revised my target from $5 to $10.
The Prepaid Card Industry
Mar. 31, 2024 11:23 AM ETPaysign, Inc. (PAYS) Stock
Qingshan Capital Management profile picture
Qingshan Capital Management
1.11K Followers
Summary
PaySign continues to experience double-digit net sales growth driven by investments in prepaid card-based payment solutions for the plasma donation industry.
The company has a strong presence with 465 plasma centers and 6.4 million cardholders, as well as sponsorship from large banks and card companies.
The recent acquisition of shares by PaySign may lead to increased demand for the stock and lower cost of capital.
jp, Makes sense to me. hopefully they reloaded in the 3.50's area.
Solid buys the final 2 or 3 minutes of market today...around 90,000 shares. Appears to me that some big trades sold near high yesterday and then shorted and made money both ways. The future appears so bright here for PAYS. Nice job on the options.
My best trade today, sold 100 May $5's @ .15.
Has shortie withstood the storm and revitalized himself?
Q1 close manana. Now a waiting game for winning #'s.
jp, bot equivalent of 3800 shares in options. Bidding for more.
Way less cash outlay.
pick up 4800 shares so far today. Have other buy orders in. Not sure where we level off since all the power is with the big boys. Picking spots to enter now at my prices. Looks like great years ahead for PAYS.
time to re-up adding in pays? where will pays level off? comments welcome-
next qtr should be exquisite. They never do pr's. Will folks see this as the growth company it now again is?-------------i still see 5 on the horizon---------4+ solidly.
lay'in off shares, grabbing june & sept 2.50's. Selling 5.00's
Bought 3.58 to 3.63. additional order in to buy.
In past times, for exercise, used to flip 500 for .10-.15.
Today, flipped 10K FOR .20.
The pps increase does not surprise me. The volume blows my mind. Good times ahead
flipped 10K also. Holding big and watching to re-add.
I'm playing too!
Have we ever had this much volume?
flipp'in 10K 's.
WHEE!!!!!!!!!!!!!!!!!!!!!!!!!!!!
WOW, it's been all over SA the last couple days. Lot of eyes there.
8.3M volume in 30 minutes. There's way more eyes here than I thought
Yea for our little favorite 3Pea!!! Soon to be bigger in all areas.
SHORT SQUEEZE!!!!!!!!!!!!!!!!!!!!
Ebrie, Thanks for checking in, your input is always appreciated.
I'm also short $5's (52% of open interest) however 1-1 with 2.50's.
Spread not too shabby.
Hope all well with you, family & all your activities.
L.
PAYS on pre market movers list. Expect lot of action today. Report is very solid and so is the future.
me happy!-----------with more to come--------volume this morning, too
Great Earnings!
Still around checking in every now and then - very impressed with the annual results and the trend here.
Steady consistent growth in plasma; with both the pharma and patient affordability lines experiencing a nice growth curve as of lately and building momentum, helping diversify revenues. They made changes at the executive rank for those sectors which appear to be bearing fruits.
Should see a nice jump here towards 5$ which is closer to fair value based on current results. Happy I sold some 2.50$ puts a week back though I’ve sold some 5$ calls on a good chunk of my position a little too early and with this momentum there’s a chance it gets called away.
Hope all is well,
E.
Spread the word...........up next- 5+
10 additional this year already
Followers
|
56
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
9631
|
Created
|
07/02/10
|
Type
|
Free
|
Moderators chilar4567 |
- Revenue for the year ending December 31, 2018 was $23.4 million, an increase of 54% compared to $15.2 million the prior year.
- Gross profit increased 70% to $11.4 million or 49% of revenues, compared to $6.7 million or 44% of revenues in 2017.period last year.
- Non-GAAP Adjusted EBITDA was $4.9 million, an increase of 65% compared to $3.0 million in 2017. Non-GAAP Fully Diluted EPS was $.09 as compared to $.06 the prior year.
- The company reiterates its previously released revenue guidance for 2019 of $38.0 to $40.0 million, representing a 62% to 71% increase compared to $23.4 million for full year 2018
as well as an adjusted EBITDA guidance at $10.0 to $12.0 million, representing a 104% to 145% increase compared to $4.9 million for full year 2018.
The PaySign platform represents a revolutionary payment processing solution that took years of development. It is a reflection of the Company's commitement to providing innovative, cost effective, customizable payment solutions to a variety of industries for multiple purposes. The platform was designed to easily incorporate new payment technologies and applications as they evolve, keeping Paysign at the forefront of payment innovation.
--> Corporate Incentives: In a market that is expected to grow to $26.5 billion by 2016, PaySign® corporate incentive cards are the perfect vehicle for
corporations looking to engage and motivate their customers, employees, and trade partners. PaySign cards are perfect for customer rebates, employee
bonuses and trade partner commissions. Examples of corporate incentive cards include prepaid cards used as incentives to purchase big ticket items such
as automobiles, smartphones and major appliances.
--> Payroll: PaySign payroll cards reduce administration costs and streamline operations for companies looking to provide an efficient payment method for
unbanked employees. The overall market for prepaid debit cards for payroll is expected to reach $66.4 billion by 2016.
--> Public Sector: Federal and local governments, educational institutions, and other public sector organizations are constantly looking to improve efficiency
and reduce costs. The PaySign card for the public sector provides an effective way to reduce costs and inefficiencies, whether related to disbursements of
public benefits or internal payments. The total prepaid card market for government payments is projected to reach $119.4 billion by 2016.
--> Pharmaceutical Co-Pay Assistance: Paysign's Allegiance Rx card is now available under the PaySign brand. Co-pay assistance cards have been
utilized by major pharmaceutical companies for brands such as Viagra®, Vyvance® and Restasis® to name a few.
--> Source Plasma Donors: Plasma collection companies nationwide can turn to the PaySign brand of cards for a customized payment solution for plasma
donors. The PaySign solution offers either a customized Plasma Web portal solution or direct integration into donor management software.
- Co-founded the Company in 2001; and driving force behind the Company's significant growth and strategic direction
- Shaping the future of the business as a premier prepaid card services leader, delivering a strong value proposition for clients and over 2 million cardholders; oversees all financial, operational, technological and strategic decisions for the company, including: technology investments, the evaluation of strategic acquisitions,new product development and the formation and cultivation of third-party relationships
- Served on the X-9 committee which developed standards for the electronic payments industry alongside IBM, Diebold, First Data, KPMG, MasterCard, Melon Bank, Visa, Wells Fargo, the Federal Reserve and others
- Attended Cal-Poly San Luis Obispo where he majored in Bio-Science
- Co-founded the Company in 2001
- 30+ years of senior IT experience
- Prior experience includes Director of Technology Planning at the Associated Press, Project Manager of implementation of Medicare Easyclaim for ANZ Bank in Australia, Coca-Cola Business Operations & Business analyst for Australia Post
- 30+ years of experience in Financial Services and BPO industries with concentration in Finance, Operations and executive leadership
- Prior experience includes CEO and CFO of Zxerex, CEO of Affina, and Vice President at American Express and Vice President at NextCard
- Bachelor of Science in Finance, minor in Accounting; and Masters in Business Administration (MBA) from Brigham Young University
- 30+ years of industry experience
- Previously at Sunrise Banks as Senior Vice President, Payments Division where she led the new prepaid business
- Prior experience includes various management positions in operations, product development, and sales and marketing at UMB Bank, Heartland Bank, and Boatmen’s Bank
- Board member of the Network Branded Prepaid Card Association and serves as Treasurer
- 13+ years of legal experience in non-traditional banking
- Previously at Republic Bank & Trust Company (Louisville, KY) as Deputy General Counsel and Vice President where he managed all legal affairs for Republic’s non-traditional bank programs, including payments, small-dollar consumer lending, commercial lending and tax related products
- B.A. in Psychology and Philosophy from the University of Kentucky and J.D. from DePaul University College of Law in Chicago, Illinois
- 20 years of experience working in the card industry, focusing on prepaid and credit products
- Previously with Global Cash Card, Inc., Sunrise Banks and Meta Payment Systems (a division of Meta Bank)
- Certified member (CAMS) of the Association of Certified Anti-Money Laundering Specialists.
- Bachelor of Science Degree from South Dakota University
- 30+ years experience in various technical roles providing enterprise IT services at several global companies
- Former Associate Director, Hosting Solutions Bristol-Myers Squibb
- Former Manager of Server Technology, The Associated Press
- 25+ years experience in various marketing roles within the Fintech industry
- Former Senior Product Marketing Manager at Fiserv
- Former Vice President, Marketing, NYSE Governance Services
Board of Directors
- Former CEO of NetSpend (2008-2013). Grew annual revenue from $129M to $351M, with over 2.4 million cardholder accounts. NetSpend acquired by Total System Services: (NYSE: TSS) for $1.4B
- Co-founder, Former President and Chief Operations Officer and Director at Euronet Worldwide (NASDAQ: EEFT). A leader in secure electronic financial transaction processing. Current market cap: 5.4B
- Sits on Board of The Brinks Company. (NYSE: BCO), CARD Corporation (Card.com), RxSavings Solutions, Balance Innovations and Align Income Share Fund
- Received a B.S. in Business Administration with majors in Finance, Economics and Real Estate from the University of Missouri,Columbia
- 35+ years in the banking industry including serving as the President and CEO of two banks in the Midwest
- Former CEO of Healthcare Services at UMB Bank, N.A a leading provider of healthcare payment solutions including health savings account (HSAs), health care spending accounts and payments technology
- 30+ years of legal experience focusing on mergers and acquisitions, public and private securities offerings, and venture capital transaction
- Serves as corporate counsel for numerous public/private companies and was formerly general counsel and board member of Swensen’sInc.
- Mr. Williams is a shareholder with Greenberg Traurig LLP and admitted to the Bar in New York and Arizona
- 30+ years of experience as a Certified Public accountant
- Founder and Managing member of Mina Llano Higgins Group, LLP
- Former CFO of Coal Brick Oven Pizzeria, Inc.
- Currently CFO for Academy of Aviation in Long Island, NY
3PEA International:
Jim McCroy
Investor Relations
Tel: 702.749.7269
IR@3PEA.com
www.3pea.com
Website
Click Here For the Company's Investor Presentation
Articles About 3PEA International
Seeking Alpha (SC Capital Group) - 3Pea Is A Payment Processor With >40% Organic Growth Selling For Half Of Peer Multiples - 2018-05-22
Seeking Alpha (Inefficient Market) - 3Pea: Strong Guidance, Uplisting, Should Propel Shares Higher - 2018-04-03
Seeking Alpha (BW Investment Visibility) - 3Pea International: Undervalued And Undercovered Turnaround Story - 2017-11-20
Analyst Coverage
Cannacord Genuity: Buy 17$ Target
Ladenburg Thalmann: Buy 14.50$ Target
Maxim Group: Buy 10.00$ Target
*This document contains projections and other forward-looking statements regarding future events. Such statements are predictions, which may involve known and unknown risks, uncertainties and other factors, which could cause the actual events or results and objections to differ materially from those expressed.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |